WARREN, N.J. (AP) — WARREN, N.J. (AP) — Aquestive Therapeutics Inc. (AQST) on Tuesday reported a loss of $8.1 million in its fourth quarter.

On a per-share basis, the Warren, New Jersey-based company said it had a loss of 12 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.

The specialty pharmaceutical company posted revenue of $13.2 million in the period, which topped Street forecasts. Three analysts surveyed by Zacks expected $11.8 million.

For the year, the company reported that its loss narrowed to $7.9 million, or 13 cents per share. Revenue was reported as $50.6 million.

Aquestive Therapeutics expects full-year revenue in the range of $48 million to $51 million.

In the final minutes of trading on Tuesday, the company's shares hit $4.19. A year ago, they were trading at 81 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News